We consider the likely biological determinants of cancer outcome, the reported effects of vitamin D3 on these in both cancerous and non‐cancerous settings, and how the effect of vitamin D3 might change depending on the integrity of tumour vitamin D receptor (VDR) signalling. Here, VDR is linked to neoplasm.